Latest News and Press Releases
Want to stay updated on the latest news?
-
HOUSTON, June 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company focused on central nervous system ("CNS") cancers, today announced...
-
Winshear provides an update on its field activities from the Thunder Bay Gold Project, NW Ontario, as well as the purchase of an assessment credit.
-
BOSTON, June 23, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people...
-
WEST DES MOINES, Iowa, June 23, 2026 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”), a leading retirement services company, today announced that it appointed veteran pensions leader Robert...
-
Combined company to operate as Serapha Bio and to advance Serapha’s potential best-in-class in vivo base editing program for Alpha-1 Antitrypsin Deficiency Serapha’s lead program SERP-01 targets the...
-
La société élargit ainsi sa gamme de FNB tout en offrant plus de choix aux investisseurs TORONTO, 23 juin 2026 (GLOBE NEWSWIRE) -- Placements AGF Inc. (« Placements AGF ») (TSX:AGF.B) a annoncé...
-
Expands ETF lineup and provides investors with greater choice TORONTO, June 23, 2026 (GLOBE NEWSWIRE) -- AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the launch of...
-
TORONTO, 23 juin 2026 (GLOBE NEWSWIRE) -- Placements AGF Inc. (Placements AGF) a annoncé aujourd’hui les distributions en espèces de juin 2026 pour le Fonds de revenu amélioré d’actions...
-
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics.Dr. Houston's deep experience...
-
WEST PALM BEACH, Florida, June 23, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an...